Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (16)
British Journal of Cancer (5)
Oncogene (3)
Leukemia (2)
Pediatric Research (2)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (30)
Correspondence (2)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Genetics
Medical research
Neuroscience
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–33 of 33 results

Advanced filters: Author: R Ambinder Clear advanced filters

Effect of material deprivation on Epstein–Barr virus infection in Hodgkin’s disease in the West Midlands

K Flavell
C Constandinou
P Murray
ResearchOpen Access09 Apr 1999
British Journal of Cancer

Volume: 80, P: 604-608
South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

K J Flavell
J P Biddulph
P G Murray
ResearchOpen Access31 Jul 2001
British Journal of Cancer

Volume: 85, P: 350-356
Risk factors for Hodgkin’s disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

F E Alexander
R F Jarrett
R A Cartwright
ResearchOpen Access03 Feb 2000
British Journal of Cancer

Volume: 82, P: 1117-1121
STRUCTURAL BASIS FOR THE MULTIPLE FUNCTIONS OF SECRETORY COMPONENT

R M Goldblum
C S Woodard
R M Denney
Research01 Apr 1984
Pediatric Research

Volume: 18, P: 255
SUCCESSFUL BONE MARROW TRANSPLANTATION IN DIGEORGE SYNDROME

Alan B Goldsobel
Guillermo R Mendoza
E Richard Stiehm
Research01 Apr 1984
Pediatric Research

Volume: 18, P: 255
Lack of Expression of the Epstein-Barr Virus (EBV) Gene Products, EBERs, EBNA1, LMP1, and LMP2A, in Breast Cancer Cells

C G Deshpande
S Badve
R Longnecker
Research01 Sept 2002
Laboratory Investigation

Volume: 82, P: 1193-1199
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Anti-TRBC1 antibody–drug conjugates may offer a more potent T cell cancer therapy by bypassing the fratricide that may be limiting the efficacy of anti-TRBC1 CAR T cells in the clinical trial for patients with T cell cancers.

Tushar D. Nichakawade
Jiaxin Ge
Suman Paul
Research27 Mar 2024
Nature

Volume: 628, P: 416-423
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody

H Dazzi
PS Hasleton
AK Chatterjee
Research01 Jun 1990
British Journal of Cancer

Volume: 61, P: 924-926
Allogeneic bone marrow transplantation for advanced Waldenstrom’s macroglobulinemia

R Martino
A Shah
L Isola
Research23 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 747-749
Successful treatment of Epstein–Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation

B Gruhn
A Meerbach
F Zintl
Research23 Dec 1999
Bone Marrow Transplantation

Volume: 24, P: 1355-1358
CD34⁺ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies

PV O’Donnell
RJ Jones
SJ Noga
Research20 Nov 1998
Bone Marrow Transplantation

Volume: 22, P: 947-955
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

KW van Besien
M de Lima
RE Champlin
Research01 May 1997
Bone Marrow Transplantation

Volume: 19, P: 977-982
High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

R Childs
C Sanchez
AJ Barrett
Research30 Oct 1998
Bone Marrow Transplantation

Volume: 22, P: 889-893
Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations

M Busson-Le Coniat
F Salomon-Nguyen
R Berger
Research02 Dec 1999
Leukemia

Volume: 13, P: 1975-1981
Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants

R Abraham
J Szer
A Grigg
Research01 Nov 1997
Bone Marrow Transplantation

Volume: 20, P: 773-777
Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation

T Tsai
S Goodman
CO Freytes
Research01 Nov 1997
Bone Marrow Transplantation

Volume: 20, P: 859-863
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin’s lymphoma

M de Lima
KW van Besien
RE Champlin
Research01 Jan 1997
Bone Marrow Transplantation

Volume: 19, P: 121-127
Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin’s lymphoma

M Bernard
C Dauriac
T Lamy
Research12 Feb 1999
Bone Marrow Transplantation

Volume: 23, P: 329-333
Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis

AA Armstrong
FE Alexander
RF Jarrett
Research12 Aug 1998
Leukemia

Volume: 12, P: 1272-1276
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial

GB Vogelsang
RJ Bitton
AD Hess
Research10 Sept 1999
Bone Marrow Transplantation

Volume: 24, P: 637-640
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Xuanyi Li
Elizabeth A. Sigworth
Jeremy L. Warner
ResearchOpen Access16 Oct 2020
Scientific Reports

Volume: 10, P: 1-13
Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

K R Meehan
B Arun
M E Lippman
Research23 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 667-673
Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates

KR Meehan
UN Verma
A Mazumder
Research01 Oct 1997
Bone Marrow Transplantation

Volume: 20, P: 643-651
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

F Fina
S Romain
P M Martin
ResearchOpen Access20 Mar 2001
British Journal of Cancer

Volume: 84, P: 783-790
Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors

AP Rapoport
R Lifton
JM Rowe
Research01 May 1997
Bone Marrow Transplantation

Volume: 19, P: 883-890
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen

J Bolaños-Meade
L Luznik
E J Fuchs
Research03 Nov 2008
Bone Marrow Transplantation

Volume: 43, P: 477-480
Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma

Paul G Murray
Guo-Hua Qiu
Qian Tao
Research12 Feb 2004
Oncogene

Volume: 23, P: 1326-1331
The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection

R F Ambinder
Reviews18 May 2009
Bone Marrow Transplantation

Volume: 44, P: 1-5
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation

T J Seng
J S W Low
Q Tao
Research24 Jul 2006
Oncogene

Volume: 26, P: 934-944
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors

J S W Low
Q Tao
W-S Hsieh
Research10 Jan 2011
Oncogene

Volume: 30, P: 1923-1935
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [¹¹C]DPA-713 PET and analysis of CSF and plasma

J M Coughlin
Y Wang
M G Pomper
ResearchOpen Access12 Apr 2016
Translational Psychiatry

Volume: 6, P: e777
Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT

E J Fuchs
L Luznik
R J Jones
Correspondence12 Jan 2009
Bone Marrow Transplantation

Volume: 43, P: 969-970
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L Ratner
D Rauch
S Jacobson
CorrespondenceOpen Access25 Mar 2016
Blood Cancer Journal

Volume: 6, P: e408

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Effect of material deprivation on Epstein–Barr virus infection in Hodgkin’s disease in the West Midlands

South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

Risk factors for Hodgkin’s disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

STRUCTURAL BASIS FOR THE MULTIPLE FUNCTIONS OF SECRETORY COMPONENT

SUCCESSFUL BONE MARROW TRANSPLANTATION IN DIGEORGE SYNDROME

Lack of Expression of the Epstein-Barr Virus (EBV) Gene Products, EBERs, EBNA1, LMP1, and LMP2A, in Breast Cancer Cells

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody

Allogeneic bone marrow transplantation for advanced Waldenstrom’s macroglobulinemia

Successful treatment of Epstein–Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation

CD34⁺ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations

Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin’s lymphoma

Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin’s lymphoma

Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis

Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors

Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen

Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma

The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation

A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [¹¹C]DPA-713 PET and analysis of CSF and plasma

Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Search

Quick links